首頁 › 囊腫性纖維化 › 加州 › Los Angeles
Los Angeles, CA 的 囊腫性纖維化 臨床試驗
9 項針對 囊腫性纖維化 的研究正在 Los Angeles（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
招募中2 期
- Keck Hospital of USC, Los Angeles
- Cedars Sinai Medical Center - Inflammatory Bowel Disease Ctr, Los Angeles
Phase 2 Study to Assess the Safety and Efficacy of ANG003
招募中2 期
- Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
招募中觀察性研究
- University of California, Los Angeles, Los Angeles
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
招募中
- Children's Hospital of Los Angeles & Anton Yelchin Cystic Fibrosis Clinic, Los Angeles
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
招募中2 期
- University of Southern California, Los Angeles
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
招募中2 期
- Children's Hospital of Los Angeles, Los Angeles
Maralixibat in Patients With Cystic Fibrosis and Constipation
招募中2/3 期
- Children's Hospital Los Angeles, Los Angeles
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
招募中觀察性研究
- Keck Medical Center of USC, Los Angeles
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
招募中觀察性研究
- Childrens Hospital Los Angeles, Los Angeles
其他城市的 囊腫性纖維化 試驗
- Boston, MA17 項研究
- Birmingham, AL16 項研究
- Philadelphia, PA15 項研究
- Kansas City, KS13 項研究
- Seattle, WA12 項研究
- Baltimore, MD12 項研究
- Denver, CO11 項研究
- Dallas, TX11 項研究
- Pittsburgh, PA11 項研究
- Cincinnati, OH10 項研究
- Aurora, CO9 項研究
- Charleston, SC8 項研究
Los Angeles 的其他研究
- 非小細胞肺癌87 項研究
- 癌症（所有類型）74 項研究
- 乳癌73 項研究
- 前列腺癌61 項研究
- 大腸直腸癌59 項研究
- 轉移性癌症57 項研究
- 卵巢癌50 項研究
- 肺癌45 項研究
- 頭頸部鱗狀細胞癌42 項研究
- 胰臟癌35 項研究
- 子宮內膜癌34 項研究
- 黑色素瘤34 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。